Company Overview
Arvinas
Sector: Healthcare
Arvinas is a biotechnology company focused on developing targeted protein degradation therapies for serious diseases, particularly in oncology and other areas of unmet medical need. The company uses a proprietary drug discovery approach designed to harness the body’s natural protein disposal system to eliminate disease-causing proteins rather than simply inhibit them. Its operations center on research, clinical development, precision medicine, and the advancement of novel therapeutic platforms for next-generation drug development.
We are tracking 1 layoff event for Arvinas as of Sep 16, 2025.